HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Clinical trial NCT06634420 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06634420
Sponsor: Intellia Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema

Start date: 2025-01-15
Primary completion: 2026-02-10
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.